Medtronic (NYSE: MDT) announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE